This study aimed to determine the effect of compound honey syrup in patients with functional dyspepsia
Design
A clinical trial with control group, with parallel groups, double-blind, randomized, phase 3 on 60 patients. Randomization prepared by Excel
Settings and conduct
Patients aged 18-60 years with Functional Dyspepsia are randomly divided into two groups according to ROME III criteria referred to the gastrointestinal clinic of Imam Hossein Hospital. Patients in the drug group use compound honey syrup. In the placebo group, placebo syrup is used.
In the beginning, consent forms and questionnaires on the severity and frequency of symptoms and quality of life are completed. After two weeks, patients are followed up and In the fourth week, patients are re-visited and questionnaires of severity and frequency of symptoms and quality of life are completed.
Participants/Inclusion and exclusion criteria
Inclusion: Patients with Functional Dyspepsia aged between 18 and 60 years. Exclusion: Pregnancy؛ Breastfeeding؛ Active urinary tract infection History of seizure؛ Concomitant use of a chemical or other herbal medicine associated with symptoms of functional indigestion؛ Any possible severe drug-related side effects؛History of a gastrointestinal ulcer or reflux disease؛ Taking anticoagulants؛Irritable bowel syndrome؛ Surgery in the esophagus and stomach, and intestines؛ Serious organ diseases such as diabetes and cardiovascular disease؛ Consumption of any drug؛ Severe mental retardation The patient's unwillingness to continue the project؛ Failure to complete the consent form؛ Warning symptoms (severe weight loss, anemia, blood in the stool, dysphagia)
Intervention groups
Group 1: Recipient of compound honey syrup
Group 2: placebo
Main outcome variables
Early satiety; Heaviness; Vomiting; Burning epigastric area; Epigastric pain; bloating; Burp; Nausea; Severity of symptoms; Frequency of symptoms.
General information
Reason for update
Acronym
IRCT registration information
IRCT registration number:IRCT20200303046677N6
Registration date:2021-02-14, 1399/11/26
Registration timing:prospective
Last update:2021-02-14, 1399/11/26
Update count:0
Registration date
2021-02-14, 1399/11/26
Registrant information
Name
rasool choopani
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 8877 3521
Email address
rchoopani@sbmu.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2021-02-18, 1399/11/30
Expected recruitment end date
2023-02-18, 1401/11/29
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
The effect of compound honey syrup on Functional Dyspepsia: a randomized double-blind placebo-controlled clinical trial
Public title
The effect of compound honey syrup on Functional Dyspepsia
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Patients aged 18-60 years
Patients with functional dyspepsia
Exclusion criteria:
Pregnancy
Breastfeeding
Active urinary tract infection
History of seizure
Concomitant use of a chemical or other herbal medicine associated with symptoms of functional indigestion
Any possible severe drug-related side effects
History of gastrointestinal ulcer or reflux disease
Taking anticoagulants
Irritable bowel syndrome
Surgery in the esophagus and stomach and intestines
Serious organ diseases such as diabetes and cardiovascular disease
Consumption of any type of drug
Severe mental retardation
The patient's unwillingness to continue the project
Failure to complete the consent form
Warning symptoms (severe weight loss, anemia, blood in the stool, dysphagia)
Age
From 18 years old to 60 years old
Gender
Both
Phase
3
Groups that have been masked
Participant
Care provider
Investigator
Sample size
Target sample size:
60
Randomization (investigator's opinion)
Randomized
Randomization description
A table of random numbers will be created by rand Excel software. Before starting, we will determined the direction of selecting random numbers (for example from top to bottom). A series of random numbers will be selected from the table, and even numbers will be assigned to the control group and odd numbers to the intervention group. The codes will be then written on drug labels and kept secretly in an envelope. Containers containing coded drugs and placebo will be provided to the physician and research assistant. Patients start receiving from the smallest number of container to enter the plan. The first patient will be entered into the research will receive the intervention related to smallest code, and the last patient will receive the biggest code.
Randomization unit: individual
Randomization tool: Random number table
Blinding (investigator's opinion)
Double blinded
Blinding description
The syrups code will be written to the drugs lable. The Prescribing physician, assistant, and patient will not be aware of syrups' content. (Double-blind).
Placebo
Used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Vice-Chancellor in Research Affairs - Shahid Beheshti University of Medical Sciences
At the beginning and end of two weeks and four weeks
Method of measurement
questionnaire
2
Description
Heaviness
Timepoint
At the beginning and end of two weeks and four weeks
Method of measurement
questionnaire
3
Description
Vomit
Timepoint
At the beginning and end of two weeks and four weeks
Method of measurement
questionnaire
4
Description
Burning epigastric area
Timepoint
At the beginning and end of two weeks and four weeks
Method of measurement
questionnaire
5
Description
Epigastric pain
Timepoint
At the beginning and end of two weeks and four weeks
Method of measurement
questionnaire
6
Description
bloat
Timepoint
At the beginning and end of two weeks and four weeks
Method of measurement
questionnaire
7
Description
Burp
Timepoint
At the beginning and end of two weeks and four weeks
Method of measurement
questionnaire
8
Description
Nausea
Timepoint
At the beginning and end of two weeks and four weeks
Method of measurement
questionnaire
9
Description
Severity of symptoms
Timepoint
At the beginning and end of two weeks and four weeks
Method of measurement
questionnaire
10
Description
Frequency of symptoms
Timepoint
At the beginning and end of two weeks and four weeks
Method of measurement
questionnaire
Secondary outcomes
empty
Intervention groups
1
Description
Intervention group: Compound honey syrup is produced by NIAK Pharmaceutical Company with the license of the Food and Drug Administration of the Ministry of Health and Medical Education, license number 0425-94-S. This syrup contains ingredients of honey, cinnamon, ginger, saffron, cardamom, kholnjan, mastaki, jozboa and basbaseh, and the instructions for making the medicine according to the manufacturer's instructions are: 1- Honey with 2 times its amount, water poured into the container and mixed. It becomes. 2- The resulting mixture is placed at a temperature of 55 to 60 ° C and under a vacuum of 50 to 70 mm Hg to find the appropriate concentration and its volume reaches two thirds of the total initial volume. 3- From the very beginning of the heat, the semi-finished medicines of ginger, cinnamon, saffron, cardamom, kholnjan, mastaki, jozboa and basbase are poured into cotton bags and hung in a container containing a mixture of water and honey for 24 hours. 4- Then the bag is taken out and the resulting material is smoothed. 5. The resulting solution is packaged in 200 cc bottles. 6- There are 2 grams of cinnamon, 2 grams of cinnamon, 2 grams of cardamom, 1 gram of ginger, 1 gram of sage, 1 gram of saffron and 1 gram of mastic, 1 gram of gooseberry and 1 gram of basil in every 100 cycles of compound honey syrup. 7- Finally, tests of physical characteristics, pH, density, viscosity, dry weight of the extract, microbial and fungal control are performed by NIAK Pharmaceutical Company on the final product.
Category
Treatment - Drugs
2
Description
Control group: Placebo syrup is also prepared by NIAC Pharmaceutical Company, which is packaged in bottles very similar to compound honey syrup. The placebo will contain water, 0.1% sodium benzoate, 0.1% saccharin and food coloring and the required amount of carboxymethylcellulose.
Category
Placebo
Recruitment centers
1
Recruitment center
Name of recruitment center
Gastroenterology Clinic of Imam Hossein Hospital
Full name of responsible person
Habib Malekpour
Street address
Shahid Madani Ave - Imam Hossein Hospital
City
Tehran
Province
Tehran
Postal code
1617763141
Phone
+98 21 7343 0000
Email
habib.malekpour@gmial.com
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Somayeh Esmaeili
Street address
No.8, Valiasr Ave., shams Ali
City
Tehran
Province
Tehran
Postal code
1516745811
Phone
+98 21 8877 3521
Email
sesmaeili@sbmu.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Shahid Beheshti University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic
Person responsible for general inquiries
Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Rasool Choopani
Position
Associate professor
Latest degree
Ph.D.
Other areas of specialty/work
Traditional Medicine
Street address
No.8, Valiasr Ave., Shams Ali
City
Tehran
Province
Tehran
Postal code
1516745811
Phone
+98 21 8877 3521
Email
rchoopani@sbmu.ac.ir
Person responsible for scientific inquiries
Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Rasool Choopani
Position
Associate Professor
Latest degree
Specialist
Other areas of specialty/work
Traditional Medicine
Street address
No.8, Valiasr Ave., Shams Ali
City
Tehran
Province
Tehran
Postal code
1516745811
Phone
+98 21 8877 3521
Fax
Email
rchoopani@sbmu.ac.ir
Person responsible for updating data
Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Rasool Choopani
Position
Associate Professor
Latest degree
Specialist
Other areas of specialty/work
Traditional Medicine
Street address
No.8, Valiasr Ave., Shams Ali
City
Tehran
Province
Tehran
Postal code
1516745811
Phone
+98 21 8877 3521
Fax
Email
rchoopani@sbmu.ac.ir
Sharing plan
Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available